Model 7000 Spirotrac
Vitalograph , Ltd. · Decision date Nov 4, 2026
What did the FDA decide?
FDA recorded a substantially equivalent decision for Model 7000 Spirotrac, submitted by Vitalograph, Ltd. under 510(k) number K260990. The decision is dated 2026-11-04 and appears in the agency's list of 510(k) final decisions rendered since October 01, 2026. Substantially equivalent in this context denotes 510(k) clearance rather than premarket approval. The record lists the specialty as Anesthesiology and the product code as BZG.
The source data identify the device only by name and do not describe its components, intended use, or any changed item, and no predicate device or comparison is given. The application relationship is limited to the clearance itself: K260990 is the 510(k) submission for Model 7000 Spirotrac, and the listed applicant is Vitalograph, Ltd. No summary or statement is available in the public information, so the basis for the equivalence determination remains unknown.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Anesthesiology
- Decision date
- Nov 4, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K260990
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Vitalograph , Ltd.
- Product code
- BZG
- Decision code
- SESE
- Decision date
- Nov 4, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Spirometer, Diagnostic.
- Applicant
- Vitalograph , Ltd.
- Product code
- BZG
- FDA device class
- 2
FDA decision timeline
K260990 received
Application receipt date recorded by FDA.
K260990 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Vitalograph , Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Ennis Co. Clare
Sources and methodology
- Original FDA record: K260990
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records